Home › Funds › Kynam Capital Management, LP › COGT

Kynam Capital Management, LP position in COGT

COGENT BIOSCIENCES INC · Health Care

Kynam Capital Management, LP reported holding 3,667,097 shares of COGT (COGENT BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$141.9M, representing 7.84% of its reported portfolio and ranking #4 among its reported holdings. Kynam Capital Management, LP has disclosed COGT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)3.67M sh
Reported value held$141.92M
Portfolio Weight7.84%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Kynam Capital Management, LP's COGT position evolved

Kynam Capital Management, LP first disclosed a stake in COGT in Q3 2023 at 2,210,125 shares (US$21.5M). The position peaked in Q4 2025 at 6,165,223 shares, worth US$219.0M. Across 12 filings, Kynam Capital Management, LP increased the stake 3 time(s), trimmed it 6 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 3,667,097 shares valued at US$141.9M — a reduction of -370,234 shares quarter over quarter.. Notable position changes include a 165% increase in Q4 2023 (shares rose 14% over the following quarter), a 45% increase in Q1 2024 (shares rose 25% over the following quarter), a 35% trim in Q1 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.21M $21.55M New
Q4 2023 5.85M $34.43M Add
Q1 2024 8.50M $57.12M Add
Q2 2024 9.26M $78.07M Add
Q3 2024 9.24M $99.79M Hold
Q4 2024 9.11M $71.02M Reduce
Q1 2025 9.11M $54.54M Hold
Q2 2025 8.49M $60.98M Reduce
Q3 2025 7.89M $113.25M Reduce
Q4 2025 6.17M $218.99M Reduce
Q1 2026 4.04M $155.40M Reduce
Q2 2026 3.67M $141.92M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About COGT and 13F data

COGT (COGENT BIOSCIENCES INC) is a Health Care company. 59 other funds we track also report a position in COGT — the largest reported positions include Fairmount Funds Management LLC (US$213.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$193.7M), TCG Crossover Management, LLC (US$187.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding COGT

All COGT fund holders →

FAQ

How long has Kynam Capital Management, LP held COGT?

Kynam Capital Management, LP has disclosed COGT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Kynam Capital Management, LP's current position in COGT?

As of Q2 2026, Kynam Capital Management, LP holds 3.67M shares of COGT (COGENT BIOSCIENCES INC), valued at $141.92M, representing 7.84% of its reported portfolio and ranking #4.

Has Kynam Capital Management, LP been buying or selling COGT?

In the latest 13F filing (Q2 2026), Kynam Capital Management, LP reduced its position in COGT. The position peaked in Q4 2025 at 6.17M shares.

Which other funds hold COGT?

Other major institutional holders of COGT include Fairmount Funds Management LLC, DEERFIELD MANAGEMENT COMPANY, L.P., TCG Crossover Management, LLC, among 59 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.